Financials
Financial year 2025
Gross margin
€ 173,775
▼ 64% vs 2024
Profit
Caution€ -228,231
▼ 409% vs 2024
Debts
Low€ 329,742
▼ 30% vs 2024
Cardiovascular Research Center Aalst from Aalst, company number BE0470425452, closed financial year 2025 with a result of € -228,231 after tax. For that financial year Cardiovascular Research Center Aalst recorded a gross margin of € 173,775 and equity of € 793,170. Compared with financial year 2024, the result moved from € 73,821 to € -228,231. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
What happened at Cardiovascular Research Center Aalst?
What happened at Cardiovascular Research Center Aalst in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 228,231 (▼ 409% vs 2024). Source: NBB ↗
- Eric Wyffels became a director. NBB
- Ward Heggermont became a director. NBB
- Peter Peytchev became a director. NBB
- Tom De Potter became a director. NBB
- New establishment in Aalst. KBO
- Jozef Bartunek became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 160,722 loss in 2021 to € 228,231 loss in 2025.
Paid € 21,926 in corporate taxes since 2021.
Best year ever: 2024, with € 73,821 profit.
On average € 30,500 of value added per employee in 2023.
A new publication or filing at Cardiovascular Research Center Aalst? We notify you, reason included.
Follow Cardiovascular Research Center AalstNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Cardiovascular Research Center Aalst are Peter Peytchev, Eric Wyffels, Jozef Bartunek, Ward Heggermont and Tom De Potter. The same people are also behind CARDIAC RESEARCH INSTITUTE, DR. E. WYFFELS, CoreAalst, DICENTRA and Dr. W. Heggermont, cardiologie.
Directors
According to the 2025 annual accounts
since 2018
since 2019
since 2002
Ward Heggermont
Director
Also active at: CARDIAC RESEARCH INSTITUTE, Dr. W. Heggermont, cardiologie, CoreAalst
since 2018
Tom De Potter
Director
since 2018
Establishments
Establishment units
Physical locations of this company
Moorselbaan 164
9300 Aalst
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 24 companies are registered at this address.
Onze-Lieve-Vrouwziekenhuis
€ 0 revenue · 2025
Vakantiedialyse
NEUROCHIRURGIE
OLV RESEARCH UNIT
€ -57,102 gross margin · 2022
CARDIAC RESEARCH INSTITUTE same network
€ 454,497 gross margin · 2025
+19 more
Details
- Company number
- 0470.425.452
- VAT number
- BE 0470.425.452
- Registered office
- Moorselbaan 164, 9300 Aalst
- Names & denominations
- Cardiovascular Research Center Aalst · CVRCA
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 9 July 1999
- Peppol
- Active · Active since 15 Dec 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg